Introduction {#sec1_1}
============

Aortoesophageal fistula is a rare, devastating and usually fatal condition which has multiple aetiological factors. The first report, in 1818, described the death of a 28-year-old soldier who exsanguinated after ingesting a beef bone fragment \[[@B1]\]. A comprehensive review, published by Hollander and Quick \[[@B2]\], which included 500 cases of fistula, identified three major causes of aortoesophageal fistula, the main aetiologic factor being aortic disease with 54.2% of cases secondary to rupture of a descending thoracic aorta aneurysm into the oesophagus. Foreign body ingestion (19.2%) and advanced esophageal carcinoma (17.0%) were the next commonest causes.

Regardless of cause, the optimal management of the fistula remains controversial, and recent literature has focused on the role of endovascular techniques and open thoracic surgery \[[@B3]\]. However, high mortality from the condition usually results from massive uncontrolled haemorrhage prior to these interventions being possible. Although non-surgical measures to control the initial haemodynamic insult caused by haemorrhage have been described \[[@B3]\], this remains a relatively unexplored area of management \[[@B4]\].

Case Report {#sec1_2}
===========

A 47-year-old Caucasian man with recently diagnosed advanced esophageal cancer attended the imaging department for an ultrasound scan. In the waiting area, the patient had a massive haematemesis and proceeded into a peri-arrest state.

He initially presented two months earlier with progressive dysphagia and weight loss. Significant past medical history included smoking and previous opioid dependence. Gastroscopy revealed a stricturing exophytic mid-esophageal lesion with an apparent fistula. A 12 × 12 Hanaro covered stent (M.I. Tech, Seoul, distributed by MTW, Wesel, Germany) was inserted across the lesion. CT confirmed an esophageal tumour in continuity with the right main bronchus with an associated right lung abscess. Despite esophageal stenting the patient developed worsening dysphagia in the following weeks. Repeat gastroscopy identified tumour overgrowth at and over the top of the original stent. An overlapping fully covered 12 × 18 Alveolus Aero stent (Alveolus, Charlotte, N.C., USA) was inserted. Despite treatment with intravenous antibiotics, an empyema subsequently developed (fig. [1](#F1){ref-type="fig"}), presumably because the bronchial fistula had been adequately sealed with the stents, creating an undrained collection in the lung which subsequently fistulated through to the pleural cavity. While awaiting a video-assisted thoracoscopic surgical procedure to drain and seal the abscess and empyema, he spontaneously drained the abscess by coughing up nearly 1 litre of pus in 24 h; this led to a dramatic improvement in his clinical state and resolution of his chest X-ray changes. He was discharged on antibiotics and further staging investigations were scheduled as an outpatient. A week before the ultrasound scan he experienced mid-thoracic pain and small episodes of haematemesis.

When he collapsed, he was tachycardic (heart rate 128 bpm) with unrecordable blood pressure. Fluid resuscitation was commenced. The patient was anaesthetised and transferred for emergency gastroscopy. This revealed an esophageal lumen full of clotted blood. Its clearance identified a large arterial bleeding point, just above the proximal end of the stent in the mid-esophagus (fig. [2a](#F2){ref-type="fig"}). A further 28 mm diameter Niti-S covered esophageal stent (Taewong Medical, Seoul, Korea) was inserted to tamponade the bleeding point (fig. [2b](#F2){ref-type="fig"}). Despite aggressive resuscitation with fluids and 8 units of blood, there was no improvement in his haemodynamic status until after stent deployment. The patient was transferred to the intensive care unit where fresh bleeding continued to be aspirated from his nasogastric tube overnight. A further 8 units of blood and 6 units of fresh frozen plasma were transfused to maintain his haemoglobin between 7 and 7.7 g/dl. With this, he remained haemodynamically stable (mean arterial blood pressure 60--80 mm Hg).

CT angiography was performed and demonstrated an aortoesophageal fistula at the level of the carina with ongoing bleeding into the mediastinum (fig. [3a](#F3){ref-type="fig"}). An endoluminal vascular stent (COOK TX2 36 mm × 120) was inserted into the thoracic aorta distal to the origin of the left subclavian artery sealing the fistula. Repeat CT angiography confirmed haemostasis (fig. [3b](#F3){ref-type="fig"}). The patient was discharged on long-term antibiotics for palliative care. He survived for 2 months at home, during which he was able to attend to his personal affairs, before dying of disseminated malignancy.

Discussion {#sec1_3}
==========

This case highlights the successful non-surgical management of a massive bleed caused by aortoesophageal fistula. The esophageal stent acted as a means to tamponade and provided partial initial control of the bleeding point. This allowed time for appropriate endovascular intervention in the form of a thoracic endoluminal stent device to further stabilise the haemodynamic status of the patient.

The challenge to recognise and treat successfully before the patient exsanguinates is probably why success stories for closure of aortoesophageal fistulas are few. High clinical suspicion and recognition of warning symptoms such as mid-thoracic pain and sentinel arterial upper gastrointestinal haemorrhage is crucial \[[@B5]\]. Transient self-limiting \'herald\' bleeds may precede fatal exsanguination by more than 24 h \[[@B6]\]. This \'window of opportunity\' allows early transfer to a specialist centre. High clinical suspicion and recognition of warning symptoms is essential.

Since Parodi et al. first reported using an endoluminal stent graft for repair of abdominal aortic aneurysms \[[@B7]\], thoracic endovascular aortic repair (TEVAR) has become more common in the management of aortoesophageal fistula \[[@B3]\], with much of the literature focusing on endovascular and open surgical management. There is still an ongoing debate as to the appropriate role of these interventions \[[@B8]\]. A recently reported successful surgical approach \[[@B9]\] advocated open transthoracic esophageal resection, cervical esophagectomy and gastrostomy. The patient had developed a fistula secondary to previous TEVAR, so the authors could not decide the best approach to salvage the thoracic aorta. Although successful in stabilising the patient, this highly invasive approach may not be suitable for patients with advanced esophageal malignancy.

Less invasive successful endovascular management of fistulas in patients with esophageal malignancy has been reported. One report \[[@B10]\] describes the use of a Dacron prosthesis interposed into the descending thoracic aorta to restore aortic flow as successful endovascular intervention; the same patient later underwent an esophagectomy for definitive treatment. A separate report \[[@B11]\] describes successful endovascular intervention to stabilise bleeding, although again this patient also went on to require further definitive gastrointestinal surgical management.

Further reports \[[@B9], [@B10], [@B11]\] appear to suggest that although TEVAR is a useful method for achieving hemodynamic stability, for definitive long-term management the patient will require some form of open surgical intervention. Of course with advanced esophageal malignancy, patients may simply not be suitable for surgery, leaving TEVAR as their only option. The problem with TEVAR remains that it does not prevent immediate exsanguination in patients admitted with fistula. It was found in patients who underwent TEVAR that early esophageal repair appeared to improve survival \[[@B12]\]. Literature on the successful esophageal management of the initial exsanguination remains limited, with the successful use of a Sengstaken-Blakemore tube prior to TEVAR being reported \[[@B13]\]. Newer techniques have been emerging, such as the use of cyanoacrylate embolisation of the fistula followed by TEVAR \[[@B14]\]. The use of esophageal stenting as a means of controlling initial exsanguination remains a relatively unexplored area of management.

In conclusion, with early recognition, esophageal stenting may have a role in the initial emergency control of bleeding due to aortoesophageal fistula, but clearly, immediate access to anaesthetic, interventional endoscopic and radiological services is mandatory. Further surgical or endovascular intervention would then be essential.
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![Chest X-ray showing development of a right-sided empyema in the patient.](crg0005-0040-f01){#F1}

![Endoscopic images. **a** A large arterial bleeding point (arrow), just above the proximal end of the stent in the mid-esophagus. The jet of blood, which was reckoned to be almost 2 mm in diameter, goes from the bottom left hand corner to the middle of the top left hand quadrant. **b** A 28 mm diameter Niti-S covered esophageal stent (Taewong Medical, Seoul, Korea) was inserted to tamponade the bleeding point.](crg0005-0040-f02){#F2}

![CT angiography images. **a** An aortoesophageal fistula at the level of the carina with ongoing bleeding into the mediastinum. The esophagus is filled with old clot without contrast, indicating successful tamponade of the fistula. **b** An endoluminal vascular stent (COOK TX2 36 mm × 120) was inserted into the thoracic aorta distal to the origin of the left subclavian artery sealing the fistula. Repeat CT angiography confirmed haemostasis.](crg0005-0040-f03){#F3}
